Associate Professor of Medicine
UNIVERSITY OF MIAMI
Miami, FL, United States
Dr. Galindo is a board certified endocrinology, clinical investigator and clinical trialist. His areas of clinical and research interest includes people with diabetes and obesity, and the use of diabetes techonology. Dr. Galindo has served as a member of several guidelines and/or international consensus documents, including: ADA Standards of Care (2023-2025), AACE Algorithm for Type 2 (2024), AACE Diabetes Guidelines 2022, DTS Inpatient use of CGM in 2020 and AID, ADA/EASD Hyperglycemic Crises in 2024.
Disclosure information not submitted.
Welcoming Remarks from Program Chairs
Friday, June 12, 2026
8:00 AM - 8:15 AM CT
Friday, June 12, 2026
4:30 PM - 5:00 PM CT